These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Gregersen N; Jensen PT; Giraldi AE Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454 [TBL] [Abstract][Full Text] [Related]
24. Hormone therapy: A to Z. Fischer C; Kallen AN; Pal L Menopause; 2013 Nov; 20(11):1204-6. PubMed ID: 23921519 [TBL] [Abstract][Full Text] [Related]
25. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention. Pinkerton JV; Pickar JH; Racketa J; Mirkin S Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444 [TBL] [Abstract][Full Text] [Related]
26. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K Menopause; 2008; 15(1):51-8. PubMed ID: 18257142 [TBL] [Abstract][Full Text] [Related]
27. US women desire greater professional guidance on hormone and alternative therapies for menopause symptom management. Ma J; Drieling R; Stafford RS Menopause; 2006; 13(3):506-16. PubMed ID: 16735949 [TBL] [Abstract][Full Text] [Related]
28. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Nappi RE; Davis SR Climacteric; 2012 Jun; 15(3):267-74. PubMed ID: 22612614 [TBL] [Abstract][Full Text] [Related]
29. Hormone therapy -- where are we now? Teede HJ; Vincent A Aust Fam Physician; 2011 May; 40(5):280-5. PubMed ID: 21597544 [TBL] [Abstract][Full Text] [Related]
30. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene. Abraham L; Pinkerton JV; Messig M; Ryan KA; Komm BS; Mirkin S Maturitas; 2014 Jul; 78(3):212-8. PubMed ID: 24837362 [TBL] [Abstract][Full Text] [Related]
31. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
32. The physiology, medical management and oral implications of menopause. Friedlander AH J Am Dent Assoc; 2002 Jan; 133(1):73-81. PubMed ID: 11811747 [TBL] [Abstract][Full Text] [Related]
33. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Utian WH Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502 [TBL] [Abstract][Full Text] [Related]
34. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study. Kramer HM; Curhan GC; Singh A; Am J Kidney Dis; 2003 Mar; 41(3):643-50. PubMed ID: 12612988 [TBL] [Abstract][Full Text] [Related]
35. Endocrinology of menopause. Edwards BJ; Li J Periodontol 2000; 2013 Feb; 61(1):177-94. PubMed ID: 23240949 [TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy. An analysis of efficacy based on evidence. Gupta G; Aronow WS Geriatrics; 2002 Aug; 57(8):18-20, 23-4. PubMed ID: 12201226 [TBL] [Abstract][Full Text] [Related]